Study-level factors associated with hematoma after ultrasound-guided vacuum-assisted breast lesion excision: a systematic review and meta-analysis using a T-P-B framework - Report - MDSpire
Advertisement
Study-level factors associated with hematoma after ultrasound-guided vacuum-assisted breast lesion excision: a systematic review and meta-analysis using a T-P-B framework
Clinical Report: Factors Linked to Hematoma Development After VAE
Overview
This systematic review and meta-analysis identified five study-level factors associated with postoperative hematoma following ultrasound-guided vacuum-assisted excision (VAE) of breast lesions. The findings are organized within a framework highlighting tumor-related, position-related, and breast- or peri-procedural management-related factors.
Background
Postoperative hematoma is a common complication following VAE, which is increasingly utilized for therapeutic lesion removal. Understanding the factors that contribute to hematoma formation is crucial. This study aims to consolidate existing evidence and provide a structured framework for risk assessment.
Data Highlights
Factor
Odds Ratio (OR)
95% Confidence Interval (CI)
Tumor Numbers
4.21
2.59–6.85
Numbers of Cutting Passes
3.87
2.16–6.95
Non-Moderate Tumor Depth
4.39
1.21–15.92
Higher Vascularity Grade
2.60
1.42–4.76
Postoperative Compression Duration < 48 h
4.34
2.53–7.45
Key Findings
Five study-level factors associated with hematoma formation were identified.
Tumor numbers and higher numbers of cutting passes significantly increased the risk of hematoma.
Non-moderate tumor depth (superficial or deep) was linked to hematoma development.
A higher vascularity grade was associated with increased hematoma risk.
Postoperative compression duration of less than 48 hours correlated with hematoma formation.
Clinical Implications
Clinicians should consider these identified factors when assessing the risk of postoperative hematoma in patients undergoing VAE. The T-P-B framework may assist in structuring perioperative discussions and risk assessments.
Conclusion
This study identifies five factors linked to hematoma development after VAE.
A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.
